<DOC>
	<DOCNO>NCT00546520</DOCNO>
	<brief_summary>Ciclesonide novel inhale corticosteroid treatment asthma . In study effect ciclesonide airway hyperresponsiveness ( AHR ) , exhale nitric oxide ( NO ) , induce sputum inflammatory biomarkers evaluate .</brief_summary>
	<brief_title>Effect Inhaled Ciclesonide Adult Patients With Asthma ( BY9010/M1-125 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Main inclusion criterion : Outpatients Written inform consent History atopic disease History perennial bronchial asthma least 6 month define ATS criteria Current use inhale short act beta2agonist require ( least 4 week prior baseline period B0 ) Stable asthma , i.e . exacerbation relevant respiratory tract infection within 2 month prior study start FEV1 â‰¥ 70 % predicted Hyperreactivity AMP ( PC20FEV1 &lt; 25 mg/ml ) Good health exception asthma Nonsmokers well exsmokers either = 10 packyears 6 month smoke abstinence Main exclusion criterion : Concomitant severe disease disease contraindication use inhaled steroid ( e.g . lung tuberculosis ) Clinically relevant abnormal laboratory value suggest unknown disease require clinical evaluation Use systemic steroid 4 week ( injectable depot steroid 6 week ) entry baseline period , 3 time last 6 month Pregnancy intention become pregnant course study , breast feeding , lack safe contraception heterosexually active female patient childbearing potential , postmenopausal le one year COPD ( i.e . chronic bronchitis emphysema ) and/or relevant lung disease Known suspect hypersensitivity inhaled steroid excipients meter dose inhaler Immunotherapy within one month prior B0 and/or entire study duration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Ciclesonide</keyword>
	<keyword>Airway hyperresponsiveness</keyword>
	<keyword>Sputum</keyword>
	<keyword>Nitric oxide</keyword>
</DOC>